Wanli Ge

633 total citations
18 papers, 392 citations indexed

About

Wanli Ge is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wanli Ge has authored 18 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Wanli Ge's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and Epigenetics and DNA Methylation (4 papers). Wanli Ge is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and Epigenetics and DNA Methylation (4 papers). Wanli Ge collaborates with scholars based in China and Germany. Wanli Ge's co-authors include Lingdong Meng, Peng Shen, Yi Miao, Hao Yuan, Kuirong Jiang, Xumin Huang, Yihan Zhang, Guodong Shi, Pengfei Wu and Taoyue Yang and has published in prestigious journals such as Oncogene, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Wanli Ge

18 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanli Ge China 12 309 251 83 39 36 18 392
Xumin Huang China 9 314 1.0× 234 0.9× 70 0.8× 29 0.7× 34 0.9× 17 376
Zhiqi Yao China 4 260 0.8× 276 1.1× 71 0.9× 39 1.0× 38 1.1× 4 383
Luxi Qian China 13 317 1.0× 258 1.0× 62 0.7× 30 0.8× 41 1.1× 25 423
Xiating Peng China 14 489 1.6× 256 1.0× 101 1.2× 28 0.7× 49 1.4× 27 609
Masahisa Ishibashi Japan 10 451 1.5× 414 1.6× 82 1.0× 27 0.7× 39 1.1× 11 566
Zhanyao Tan China 10 367 1.2× 210 0.8× 72 0.9× 76 1.9× 38 1.1× 10 461
Weimei Tang China 13 357 1.2× 199 0.8× 99 1.2× 45 1.2× 73 2.0× 21 447
Nanhang Lu China 7 263 0.9× 151 0.6× 86 1.0× 39 1.0× 48 1.3× 16 357
Chuanchao He China 12 295 1.0× 166 0.7× 71 0.9× 28 0.7× 50 1.4× 21 411
Lilin Ma China 10 317 1.0× 233 0.9× 130 1.6× 21 0.5× 53 1.5× 18 440

Countries citing papers authored by Wanli Ge

Since Specialization
Citations

This map shows the geographic impact of Wanli Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanli Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanli Ge more than expected).

Fields of papers citing papers by Wanli Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanli Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanli Ge. The network helps show where Wanli Ge may publish in the future.

Co-authorship network of co-authors of Wanli Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Wanli Ge. A scholar is included among the top collaborators of Wanli Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanli Ge. Wanli Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Yan, Wanli Ge, Shaojun Wang, et al.. (2024). MiR-548t-5p regulates pancreatic ductal adenocarcinoma metastasis through an IL-33-dependent crosstalk between cancer cells and M2 macrophages. Cell Cycle. 23(2). 169–187. 3 indexed citations
2.
Ge, Wanli, Lingdong Meng, Chaoqun Hou, et al.. (2023). The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer. Journal of Immunology Research. 2023. 1–21. 21 indexed citations
3.
Meng, Lingdong, Yihan Zhang, Pengfei Wu, et al.. (2022). CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Molecular Cancer. 21(1). 121–121. 54 indexed citations
4.
Chen, Qun, Jiajia Li, Peng Shen, et al.. (2022). Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star. Cell & Bioscience. 12(1). 97–97. 15 indexed citations
5.
Ge, Wanli, Lingdong Meng, Qun Chen, et al.. (2022). Suppressive effect of YY1‑mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma. Oncology Letters. 24(6). 457–457. 2 indexed citations
6.
Shen, Peng, Wanli Ge, Taoyue Yang, et al.. (2021). Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer. Oncogene. 40(15). 2772–2784. 20 indexed citations
7.
Chen, Qun, Wujun Wang, Hao Yuan, et al.. (2021). Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell & Bioscience. 11(1). 86–86. 12 indexed citations
8.
Cao, Meng, Pengbo Zhang, Pengfei Wu, et al.. (2021). DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. BioMed Research International. 2021(1). 6530298–6530298. 4 indexed citations
9.
Yang, Taoyue, Peng Shen, Qun Chen, et al.. (2021). FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 261–261. 53 indexed citations
10.
Ge, Wanli, Qun Chen, Lingdong Meng, et al.. (2020). The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death and Disease. 11(4). 294–294. 20 indexed citations
11.
Ge, Wanli, Guodong Shi, Xumin Huang, et al.. (2020). Optimization of internal reference genes for qPCR in human pancreatic cancer research. Translational Cancer Research. 9(4). 2962–2971. 5 indexed citations
13.
Zong, Qingqing, et al.. (2020). <p>Establishment of Simple Nomograms for Predicting Axillary Lymph Node Involvement in Early Breast Cancer</p>. Cancer Management and Research. Volume 12. 2025–2035. 15 indexed citations
14.
Chen, Qun, Chuang Yang, Lei Chen, et al.. (2019). YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways. British Journal of Cancer. 121(11). 912–921. 32 indexed citations
15.
Chen, Qun, Jingjing Zhang, Wanli Ge, et al.. (2019). YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER/STAT3/MMP2 signaling pathway. Cancer Letters. 463. 37–49. 43 indexed citations
16.
Chen, Lei, Jingjing Zhang, Qun Chen, et al.. (2019). Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS. International Journal of Cancer. 147(1). 175–188. 23 indexed citations
17.
Chen, Qun, Hao Yuan, Guodong Shi, et al.. (2018). Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case&ndash;control studies. OncoTargets and Therapy. Volume 11. 2709–2723. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026